drugset / Trial / NCT06554821

A Study to Investigate the Effect of Oral Ticagrelor on the Pharmacokinetics of Oral Rosuvastatin When Given in Healthy Participants

NCT06554821

Phase 1 Completed 28 enrolled AstraZeneca Parexel · collab
RandomizedParallel-groupOpen-labelOther

Summary

The purpose of this study is to measure the effect of ticagrelor on the pharmacokinetics (PK) of rosuvastatin in healthy participants.

Timeline

Start
2024-08-05
Primary completion
2024-10-08
Completion
2024-10-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule Oral
Subject Ticagrelor Small molecule 90 mg Oral

Indications

No indication recorded.